The Global Bone Regeneration Market Revenue is expected to be valued at US$ 5,380.75 million in 2023 and to grow at a CAGR of 3.8% to US$ 7,827.8 million by 2033. In terms of product type, bone graft substitutes dominated the market in 2022, accounting for 81.2% of the total.
The need for reconstructive surgery, combined with the global frequency of bone disorders, has increased demand for bone regenerating procedures. According to statistics, roughly 10% of men and 18% of women over the age of 60 have symptomatic osteoarthritis. Aside from that, a significant increase in bone injuries and hip fractures, particularly among athletes, has led in an increased need for Bone Regeneration surgeries.
Bone graft alternatives are used to treat delayed fracture unions, fuse the spine, mend bone deformities, and fill cavities caused by a variety of reasons. Synthetics, bone void fillers, bone morphogenetic proteins, demineralized bone matrix, autografts, allografts, and other sources are used to make the substance.
Unlock growth potential with industry expertise. Download your market sample report now: https://www.futuremarketinsights.com/reports/sample/rep-gb-15486
The bulk of orthopaedic disorders are caused by paediatric deformity, degenerative illnesses, musculoskeletal oncology, spinal deformity, and situations of trauma and damage. These issues are particularly visible in developing economies such as India, China, and Brazil.
As more people acquire musculoskeletal difficulties or illnesses, the market for Bone Regeneration is expected to grow. Over the projected period (2023 to 2033), the worldwide Bone Regeneration market is expected to develop at a CAGR of 3.8%.
Bone Regeneration Market Drivers:
Degenerative joint diseases are growing increasingly widespread, which is helping the sector thrive. Numerous osteoarthritis patients have severe joint degradation in the absence of disease treatment. To arrest osteoarthritis-related increasing joint degradation, surgery utilising bone replacements and transplants is required. According to the American College of Rheumatology, advancements in biomaterial and tissue engineering may open up new avenues for combining surgical procedures in osteoarthritis.
Low-level electrical fields, according to medical authorities, enhance the body’s natural bone-healing mechanisms. This application is currently using the same technology. Researchers are exploiting advanced healthcare technologies to achieve further advances, such as establishing novel ways for encouraging Bone Regeneration or improving existing devices.
Bone Regeneration Market Regional Insights:
The United States dominated the North American market in 2021, with a total share of approximately 73.7%, and is predicted to increase at the same rate over the forecast period. The United States is regarded as the most appealing market due to the rising occurrence of joint disorders, which has resulted in an increase in surgical treatments.
Get Bone Regeneration Market Report At a Discounted Price: https://www.futuremarketinsights.com/request-discount/rep-gb-15486
During the projected period, Germany is expected to demonstrate a CAGR of roughly 3.7% in the Europe Bone Regeneration market. The availability of customised bone transplants and replacement treatments is driving growth.
In 2021, China owned a 50.3% share of the East Asia Bone Regeneration market, which is expected to grow at a CAGR of 4.3% during the forecast period. Healthcare experts are experiencing a paradigm change in regenerative medicine technology as China’s healthcare system develops.
Bone Regeneration Market Competition:
The market for Bone Regeneration is moderately fragmented, and there exist, several local, emerging, as well as established players within the market sphere. Key players have initiated promotional activities to introduce new products with continued collaboration and expansion activities
- In November 2021, Johnson & Johnson received 510(k) FDA clearance for the VELYSTM Robotic-Assisted Solution for use with the ATTUNE® Total Knee System, allowing surgeons to streamline their current workflows on a typical orthopaedic procedure.
- Altapore Shape bioactive bone graft, the newest addition to Baxter’s line of next-generation bone graft substitutes, received FDA approval in September 2020.
Bone Regeneration Market Key Players:
- Medtronic plc.
- Stryker Corporation
- DePuy Synthes, Inc.
- Integra Lifesciences Holdings Corporation
- Zimmer Biomet Holdings, Inc.
- Xtant Medical Holdings, Inc.
- Arthrex, Inc.
- Baxter International Inc.
- Others
Request Tailored Insights to Outperform in the Bone Regeneration Market: https://www.futuremarketinsights.com/customization-available/rep-gb-15486
Key Segments Covered in Bone Regeneration Industry Research:
By Product:
- Bone Grafts Substitutes
- Allografts
- Demineralized Bone Matrix(DBM)
- Others
- Xenograft
- Autografts
- Synthetic Bone Graft
- Bone Morphogenetic Protein(BMP)
- Allografts
- Bone Growth Stimulators
- Non-Invasive Electrical Bone Growth Stimulators
- Invasive Electrical Bone Growth Stimulators
By Application:
- Osteoarthritis (OA)
- Osteoporosis
- Rheumatoid Arthritis (RA)
- Spinal Disorders
- Dentistry
- Craniomaxillofacial (CMF)
- Trauma Cases
By Age Group:
- Pediatric
- Adults
- Geriatric
By End User:
- Hospitals
- Orthopedic Clinics
- Ambulatory Surgical Centers
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs
